Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2022 ASCO Annual Meeting

In this module, John M. Burke, MD; Shaji Kumar, MD; and Eunice S. Wang, MD, discuss key findings in hematologic malignancies presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

First, Eunice S. Wang, MD, will explore top studies related to the care of patients with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). John M. Burke, MD, will then review the most clinically relevant studies in chronic lymphocytic leukemia (CLL) and other lymphomas including updates in advanced classic Hodgkin lymphoma (cHL), mantle cell lymphoma (MCL), relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), and R/R follicular lymphoma (FL). Finally, Shaji Kumar, MD, will discuss key studies on the care of patients with multiple myeloma (MM).

The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slidesets, which can be found here or downloaded by clicking any of the slide thumbnails in the module alongside the expert commentary.

Clinical Care Options plans to measure the educational impact of this activity. A few questions will be asked twice: once at the beginning of the activity and then again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.